BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27194163)

  • 1. Do evoked potentials contribute to the functional follow-up and clinical prognosis of multiple sclerosis?
    Giffroy X; Maes N; Albert A; Maquet P; Crielaard JM; Dive D
    Acta Neurol Belg; 2017 Mar; 117(1):53-59. PubMed ID: 27194163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal evoked potentials for functional quantification and prognosis in multiple sclerosis.
    Giffroy X; Maes N; Albert A; Maquet P; Crielaard JM; Dive D
    BMC Neurol; 2016 Jun; 16():83. PubMed ID: 27245221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of multimodal evoked potentials in multiple sclerosis prognostication.
    Ramanathan S; Lenton K; Burke T; Gomes L; Storchenegger K; Yiannikas C; Vucic S
    J Clin Neurosci; 2013 Nov; 20(11):1576-81. PubMed ID: 23827173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological markers and predictors of the disease course in primary progressive multiple sclerosis.
    Schlaeger R; D'Souza M; Schindler C; Grize L; Kappos L; Fuhr P
    Mult Scler; 2014 Jan; 20(1):51-6. PubMed ID: 23756680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early abnormalities of evoked potentials and future disability in patients with multiple sclerosis.
    Kallmann BA; Fackelmann S; Toyka KV; Rieckmann P; Reiners K
    Mult Scler; 2006 Feb; 12(1):58-65. PubMed ID: 16459720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined evoked potentials as markers and predictors of disability in early multiple sclerosis.
    Schlaeger R; D'Souza M; Schindler C; Grize L; Kappos L; Fuhr P
    Clin Neurophysiol; 2012 Feb; 123(2):406-10. PubMed ID: 21778106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of MS disability by multimodal evoked potentials: investigation during relapse or in the relapse-free interval?
    Schlaeger R; D'Souza M; Schindler C; Grize L; Kappos L; Fuhr P
    Clin Neurophysiol; 2014 Sep; 125(9):1889-92. PubMed ID: 24555924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score.
    Invernizzi P; Bertolasi L; Bianchi MR; Turatti M; Gajofatto A; Benedetti MD
    J Neurol; 2011 Nov; 258(11):1933-9. PubMed ID: 21479648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of long-term disability in multiple sclerosis.
    Schlaeger R; D'Souza M; Schindler C; Grize L; Dellas S; Radue EW; Kappos L; Fuhr P
    Mult Scler; 2012 Jan; 18(1):31-8. PubMed ID: 21868486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal evoked potentials measure and predict disability progression in early relapsing-remitting multiple sclerosis.
    Jung P; Beyerle A; Ziemann U
    Mult Scler; 2008 May; 14(4):553-6. PubMed ID: 18562509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring multiple sclerosis by multimodal evoked potentials: Numerically versus ordinally scaled scoring systems.
    Schlaeger R; Hardmeier M; D'Souza M; Grize L; Schindler C; Kappos L; Fuhr P
    Clin Neurophysiol; 2016 Mar; 127(3):1864-71. PubMed ID: 26754876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined visual and motor evoked potentials predict multiple sclerosis disability after 20 years.
    Schlaeger R; Schindler C; Grize L; Dellas S; Radue EW; Kappos L; Fuhr P
    Mult Scler; 2014 Sep; 20(10):1348-54. PubMed ID: 24574192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting falls in multiple sclerosis: Do electrophysiological measures have a better predictive accuracy compared to clinical measures?
    Chinnadurai SA; Gandhirajan D; Srinivasan AV; Kesavamurthy B; Ranganathan LN; Pamidimukkala V
    Mult Scler Relat Disord; 2018 Feb; 20():199-203. PubMed ID: 29414299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodal evoked potentials follow up in multiple sclerosis patients under fingolimod therapy.
    Iodice R; Carotenuto A; Dubbioso R; Cerillo I; Santoro L; Manganelli F
    J Neurol Sci; 2016 Jun; 365():143-6. PubMed ID: 27206893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evoked potentials and disability in multiple sclerosis: A different perspective to a neglected method.
    Kiylioglu N; Parlaz AU; Akyildiz UO; Tataroglu C
    Clin Neurol Neurosurg; 2015 Jun; 133():11-7. PubMed ID: 25819634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early disturbances in multimodal evoked potentials as a prognostic factor for long-term disability in relapsing-remitting multiple sclerosis patients.
    London F; El Sankari S; van Pesch V
    Clin Neurophysiol; 2017 Apr; 128(4):561-569. PubMed ID: 28231474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic biomarkers in primary progressive multiple sclerosis: Validating and scrutinizing multimodal evoked potentials.
    Hardmeier M; Schlaeger R; Lascano AM; Toffolet L; Schindler C; Gobbi C; Lalive P; Kuhle J; Kappos L; Fuhr P
    Clin Neurophysiol; 2022 May; 137():152-158. PubMed ID: 35316624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodal evoked potentials to assess the evolution of multiple sclerosis: a longitudinal study.
    Leocani L; Rovaris M; Boneschi FM; Medaglini S; Rossi P; Martinelli V; Amadio S; Comi G
    J Neurol Neurosurg Psychiatry; 2006 Sep; 77(9):1030-5. PubMed ID: 16735397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical scales in progressive MS: predicting long-term disability.
    Bosma LV; Kragt JJ; Knol DL; Polman CH; Uitdehaag BM
    Mult Scler; 2012 Mar; 18(3):345-50. PubMed ID: 21868487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motor evoked potentials and disability in secondary progressive multiple sclerosis.
    Facchetti D; Mai R; Micheli A; Marcianó N; Capra R; Gasparotti R; Poloni M
    Can J Neurol Sci; 1997 Nov; 24(4):332-7. PubMed ID: 9398981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.